AIMCA
GBT

Alberta Investment Management Corp (AIMCo)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-75,100
Closed -$5.11M – 1353
2022
Q3 		$5.11M Buy
+75,100
New +$4.14M 0.04% 459

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s GBT Position: Q4 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 75,100 shares — an estimated $5.11M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $5.11M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 75,100 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $5.11M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Global Blood Therapeutics, Inc. position peaked at $5.11M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2022, filed 14 Feb 2023.